Biomedical Research Institute of Jiangsu Wuzhong Medicine Group

The Biomedical Research Institute of Jiangsu Wuzhong Medicine Group serves as the core research and development engine for its parent company, Jiangsu Wuzhong Pharmaceutical Group. Based in Suzhou, the institute focuses on the discovery and clinical development of innovative drugs in oncology, anti-infectives, and cardiovascular health. In recent years, it has significantly expanded into the medical aesthetics sector, developing high-end products such as recombinant collagen and poly-L-lactic acid (PLLA) fillers. The institute operates comprehensive technology platforms for small molecule synthesis and recombinant protein engineering to support its diverse pipeline. By integrating basic research with clinical application, it facilitates the group's strategic transition toward becoming an innovation-led biopharmaceutical leader in China.